Dr. Bryan Lee Balentine, MD

Dr. Balentine practices at Baptist Medical Center South in Montgomery, Alabama, part of University of Alabama at Birmingham.

Dr. Balentine's NPI, 1881614451, was assigned on July 19, 2006. Dr. Balentine holds Alabama license 25466.

Dr. Balentine's primary practice is Baptist Medical Center South, at 2105 East South Boulevard, Montgomery, AL 36116 in Montgomery County. The practice phone is (334) 288-2100.

Dr. Balentine's primary practice is Baptist Medical Center South in Montgomery, Alabama, part of University of Alabama at Birmingham. The medical group on file is Paragon Contracting Services. Dmand AI also links Dr. Balentine to 8 more medical groups, 2 group practices and clinics, 1 physician office and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balentine practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Balentine's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Balentine is licensed in Alabama.

CMS data shows 177 Medicare services from Dr. Balentine across 4 procedure codes in 2024, for 131 Medicare patients. Medicare paid $15,383 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Balentine in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Balentine's median patient age at 66, with 30% women.

In 2024, Dr. Balentine wrote 176 Medicare Part D claims for 115 patients. 98% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $244 in total drug cost. In 2023, CMS named 72 claims across 4 drugs.

CMS Open Payments shows 32 general payments to Dr. Balentine from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $776.